rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    CPIX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Cumberland Pharmaceuticals Q3 Earnings Call Highlights
      Nov 11Yahoo FinanceCPIX
      Cumberland Q3 2026 Earnings Call Transcript
      Nov 10BenzingaCPIX
      CUMBERLAND PHARMACEUTICALS REPORTS Q3 2026 FINANCIAL RESULTS & COMPANY UPDATE
      Nov 10Yahoo FinanceCPIX
      CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q3 2026 FINANCIAL RESULTS
      Nov 3Yahoo FinanceCPIX
      Cumberland Pharmaceuticals Inc. (CPIX) Discusses Duchenne Cardiomyopathy NDA Submission and Product Development Strategy - Slideshow (NASDAQ:CPIX) 2026-10-28
      Oct 28Seeking AlphaCPIX
      Cumberland Pharmaceuticals: The FDA's Phase 3 Question Is Hard To Ignore (NASDAQ:CPIX)
      Oct 27Seeking AlphaCPIX
      Cumberland announces ifetroban NDA filing plan after shares plummet

      Cumberland plans an NDA for ifetroban in Duchenne cardiomyopathy after FDA talks. Read more here

      Oct 26Seeking AlphaCPIX
      Cumberland Pharmaceuticals Begins Rolling FDA NDA for Dyscorban in Duchenne Cardiomyopathy
      Oct 26Yahoo FinanceCPIX
      CUMBERLAND PHARMACEUTICALS ANNOUNCES PLANS TO FILE NEW DRUG APPLICATION FOR IFETROBAN DMD PROGRAM

      Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), ("Cumberland" or the "Company") an innovation-focused biopharmaceutical company developing new products for rare diseases, today provided an update on its ifetroban product candidate in development as a potential treatment for the cardiomyopathy associated with Duchenne muscular dystrophy ("DMD"). The Company announced plans to submit a New Drug Application ("NDA") to the U.S. Food and Drug Administration ("FDA") for ifetroban as a potential treatm

      Oct 26Yahoo FinanceCPIX
      Cumberland Pharmaceuticals stock tumbles on trial results
      Oct 23Yahoo FinanceCPIX
      Why is Cumberland Pharmaceuticals stock sliding today?
      Oct 23Investing.comCPIX
      Cumberland Pharmaceuticals Announces ASSIST-SSc Trial Top-Line Results
      Oct 23Yahoo FinanceCPIX
      CUMBERLAND PHARMACEUTICALS PROVIDES UPDATED WEBCAST REGISTRATION LINK FOR IFETROBAN DMD PROGRAM CALL
      Oct 23Yahoo FinanceCPIX
      CUMBERLAND PHARMACEUTICALS ANNOUNCES NATIONAL CALL TO PRESENT AN UPDATE ON ITS IFETROBAN DMD PROGRAM
      Oct 19Yahoo FinanceCPIX

      This is the newest page. Registered accounts read further back.